Suvorexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study.
Kishi T, Sakuma K, Okuya M, Ninomiya K, Oya K, Kubo M, Matsui Y, Nomura I, Okuyama Y, Matsunaga S, Iwata N.
Kishi T, et al. Among authors: sakuma k.
Neuropsychopharmacol Rep. 2019 Sep;39(3):252-255. doi: 10.1002/npr2.12069. Epub 2019 Jul 8.
Neuropsychopharmacol Rep. 2019.
PMID: 31283862
Free PMC article.
Clinical Trial.